review Open AccessTop 1% cited
IgE, mast cells, basophils, and eosinophils
Journal of Allergy and Clinical Immunology · 2010 · Vol. 125(2) · pp. S73–S80
Kelly D. Stone✉(National Institute of Allergy and Infectious Diseases)Calman Prussin(National Institute of Allergy and Infectious Diseases)Dean D. Metcalfe(National Institute of Allergy and Infectious Diseases)
Asthma and respiratory diseasesMast cells and histamineUrticaria and Related ConditionsMast (botany)Immunoglobulin EEosinophilImmunologyMast cellBiologyAsthmaAntibody
MeSH terms
OmalizumabAnimalsAntibodies, Anti-IdiotypicAntibodies, MonoclonalBasophilsCell DifferentiationCell MovementEosinophilsHumansHypersensitivity, ImmediateImmunoglobulin EMast CellsBiomarkersCell DegranulationCytokines
Citations
1,639
FWCI
48.87
field-weighted impact
References
127
Percentile
100%
vs. same field & year
Citations per year
Cited by
Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
Allergy · 2019 · 458 citations
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Journal of Allergy and Clinical Immunology · 2010 · 1,827 citations
A cross-population atlas of genetic associations for 220 human phenotypes
Nature Genetics · 2021 · 2,289 citations
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Allergy · 2008 · 4,669 citations
NLR: An incipient marker to monitor inflammation, overtraining, and recovery in athletes
International Journal of Physical Education Sports and Health · 2022 · 1 citations
References
Mechanisms of eosinophil-associated inflammation
Journal of Allergy and Clinical Immunology · 2000 · 776 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.